North Dakota 2025-2026 Regular Session

North Dakota House Bill HB1543

Introduced

1/20/25

Refer

1/20/25

Report Pass

2/5/25

Engrossed

2/11/25

Refer

2/17/25

Report Pass

3/7/25

Enrolled

3/21/25

Passed

3/26/25

Caption

AN ACT to provide for a legislative management study regarding prescription drug pricing and the maximum fair price as determined by the federal government.

Latest ND HB1543 Activity

View All Events: ND 2025-2026 Regular Session HB1543

Companion Bills

No companion bills found.

Previously Filed As

ND SB2370

AN ACT to provide for a legislative management study regarding prescription drug transparency reporting under the federal drug discount program.

ND HB1329

AN ACT to provide for a legislative management study regarding the establishment of a government spending database.

ND SB2360

AN ACT to provide for a legislative management study regarding geothermal energy.

ND HB1151

AN ACT to provide for a legislative management study regarding the regulation of cell-cultured protein.

ND SB368

Provides for prescription drug pricing. (8/1/26) (OR +$270,360 SG EX See Note)

ND SB369

Provides for prescription drug pricing. (1/1/27) (EG SG EX See Note)

Establishes a pilot program on the referenced rate for prescription drugs; relates to reducing the cost of prescription drugs by establishing maximum wholesale drug prices that are the same as the prices in Canada.

ND S01351

Similar Bills

No similar bills found.